Compare Colgate-Palmolive Company (CL) vs SpaceX (SPCX) Price & Performance
Price performance (Past 24H)
Key statistics
Key statistics
Colgate-Palmolive Company vs SpaceX — how do they compare? Colgate-Palmolive Company trades at $92 (market cap $74.26B), while SpaceX trades at $134.68 (market cap $1.83T). The key difference: SpaceX is far larger — about 24.6× Colgate-Palmolive Company's market cap, and Colgate-Palmolive Company pays a 2.28% dividend while SpaceX pays none. Which is the better fit depends on your goals.
| CL | SPCX | |
|---|---|---|
Market Cap | $74.26B | $1.83T |
Sector | Consumer Staples | Technology |
52-Week High | $99.14 | $202.09 |
52-Week Low | $74.98 | $108.27 |
Enterprise Value | $80.74B | $1.77T |
Dividend Yield | 2.28% | — |
Aura AI Summary
Signals from Pluang's Aura AI — not financial advice
Aura AI Summary
Signals from Pluang's Aura AI — not financial advice
Colgate-Palmolive (CL) trades at $93.27, up 0.29% on the day, with a bullish technical signal and consistent earnings beats. The company reported Q2 2026 EPS of $0.99, exceeding estimates, driven by strong margins and organic growth in emerging markets, though North American performance remains weak. Operating cash flow remains robust at $4.2 billion in 2025, supporting shareholder returns.
Outlook is mixed: valuation appears stretched with a P/E of 36.72, but analyst consensus targets $99.10. Risks include competitive pressures in North America and high debt levels. The stock offers a stable dividend, but growth concerns and insider selling warrant caution.
SpaceX (SPCX) trades at $133.11, up 15.83% in 24 hours, reclaiming its $135 IPO price amid bullish technical signals and positive analyst sentiment. The stock shows strong momentum with resistance near $140 and support at $121. Despite negative profitability margins and high valuation ratios, robust revenue growth and significant capital investments in AI and infrastructure signal long-term ambition. Recent news highlights a major chip plant investment and a new satellite launch contract, fueling investor optimism.
Outlook is cautiously optimistic with a consensus price target of $228.52, though risks include persistent losses, high capex, and competitive pressures. The stock offers growth potential driven by Starlink's performance and strategic expansions, but investors must weigh volatility and execution risks against bullish analyst coverage.
Returns comparison
Trailing returns across standard periods
Returns comparison
Trailing returns across standard periods
Top news
Latest headlines on both assets
Top news
Latest headlines on both assets
About Colgate-Palmolive Company
Since its founding in 1806, Colgate-Palmolive has grown to become a leading global consumer product company. In addition to its namesake oral care line, the firm manufactures shampoos, shower gels, deodorants, and home care products that are sold in over 200 countries (international sales account for about 70% of its consolidated total, including approximately 45% from emerging regions). It also owns specialty pet food maker Hill's, which sells its products through veterinarians and specialty pet retailers.
Read more on CL →About SpaceX
SpaceX is the world's leading aerospace manufacturer and launch provider. It designs and operates reusable rockets, spacecraft, and Starlink, a global satellite internet service with over 10 million subscribers across 160 countries.
Read more on SPCX →
